Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?
Clin Infect Dis. 2019 Mar 18;:
Authors: Fabre V, Amoah J, Cosgrove SE, Tamma PD
In a multicenter, observational propensity-score weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bloodstream infections, patients receiving short-course (median 9 days, interquartile range [IQR] 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median 16 days, IQR 14-17).
PMID: 30882137 [PubMed - as supplied by publisher]